These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10509910)

  • 1. Syntheses of novel antitumor dihydroxanthone derivatives with inhibitory activity against DNA topoisomerase II.
    Sato S; Suga Y; Yoshimura T; Nakagawa R; Tsuji T; Umemura K; Andoh T
    Bioorg Med Chem Lett; 1999 Sep; 9(18):2653-6. PubMed ID: 10509910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DNA topoisomerases by nidulalin A derivatives.
    Sato S; Fukuda Y; Nakagawa R; Tsuji T; Umemura K; Andoh T
    Biol Pharm Bull; 2000 Apr; 23(4):511-2. PubMed ID: 10784438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 2-(thienyl-2-yl or -3-yl)-4-furyl-6-aryl pyridine derivatives and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
    Thapa P; Karki R; Choi H; Choi JH; Yun M; Jeong BS; Jung MJ; Nam JM; Na Y; Cho WJ; Kwon Y; Lee ES
    Bioorg Med Chem; 2010 Mar; 18(6):2245-2254. PubMed ID: 20188578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrimidoquinazoline-based antitumor agents. Design of topoisomerase II to DNA cross-linkers with activity against protein kinases.
    Skibo EB; Huang X; Martinez R; Lemus RH; Craigo WA; Dorr RT
    J Med Chem; 2002 Dec; 45(25):5543-55. PubMed ID: 12459022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel angular benzophenazines: dual topoisomerase I and topoisomerase II inhibitors as potential anticancer agents.
    Vicker N; Burgess L; Chuckowree IS; Dodd R; Folkes AJ; Hardick DJ; Hancox TC; Miller W; Milton J; Sohal S; Wang S; Wren SP; Charlton PA; Dangerfield W; Liddle C; Mistry P; Stewart AJ; Denny WA
    J Med Chem; 2002 Jan; 45(3):721-39. PubMed ID: 11806724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BN 80927: a novel homocamptothecin with inhibitory activities on both topoisomerase I and topoisomerase II.
    Lavergne O; Harnett J; Rolland A; Lanco C; Lesueur-Ginot L; Demarquay D; Huchet M; Coulomb H; Bigg DC
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2599-602. PubMed ID: 10498216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2- or 6-(1-azidoalkyl)-5,8-dimethoxy-1,4-naphthoquinone: synthesis, evaluation of cytotoxic activity, antitumor activity and inhibitory effect on DNA topoisomerase-I.
    Chae GH; Song GY; Kim Y; Cho H; Sok DE; Ahn BZ
    Arch Pharm Res; 1999 Oct; 22(5):507-14. PubMed ID: 10549580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the discovery and development of quinolones and analogs as antitumor agents.
    Xia Y; Yang ZY; Morris-Natschke SL; Lee KH
    Curr Med Chem; 1999 Mar; 6(3):179-94. PubMed ID: 10219099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of rotenoid derivatives with cytotoxic and topoisomerase II inhibitory activities.
    Sangthong S; Krusong K; Ngamrojanavanich N; Vilaivan T; Puthong S; Chandchawan S; Muangsin N
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4813-8. PubMed ID: 21741833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of new topoisomerase II inhibitors based upon a quinobenzoxazine self-assembly model.
    Zeng Q; Kwok Y; Kerwin SM; Mangold G; Hurley LH
    J Med Chem; 1998 Oct; 41(22):4273-8. PubMed ID: 9784102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dicationic bis(9-methylphenazine-1-carboxamides): relationships between biological activity and linker chain structure for a series of potent topoisomerase targeted anticancer drugs.
    Gamage SA; Spicer JA; Finlay GJ; Stewart AJ; Charlton P; Baguley BC; Denny WA
    J Med Chem; 2001 Apr; 44(9):1407-15. PubMed ID: 11311063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives.
    Zhou Y; Xu X; Sun Y; Wang H; Sun H; You Q
    Bioorg Med Chem Lett; 2013 May; 23(10):2974-8. PubMed ID: 23566520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor agents. I. DNA topoisomerase II inhibitory activity and the structural relationship of podophyllotoxin derivatives as antitumor agents.
    Terada T; Fujimoto K; Nomura M; Yamashita J; Kobunai T; Takeda S; Wierzba K; Yamada Y; Yamaguchi H
    Chem Pharm Bull (Tokyo); 1992 Oct; 40(10):2720-7. PubMed ID: 1334447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bis(phenazine-1-carboxamides): structure-activity relationships for a new class of dual topoisomerase I/II-directed anticancer drugs.
    Spicer JA; Gamage SA; Rewcastle GW; Finlay GJ; Bridewell DJ; Baguley BC; Denny WA
    J Med Chem; 2000 Apr; 43(7):1350-8. PubMed ID: 10753472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic inhibitors of DNA topoisomerase I and II.
    Katayama H; Kawada Y; Kaneko K; Oshiyama T; Takatsu N
    Chem Pharm Bull (Tokyo); 1999 Jan; 47(1):48-53. PubMed ID: 9987826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
    Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
    J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitumor activity of 4-aminomethylthioxanthenone and 5-aminomethylbenzothiopyranoindazole derivatives.
    Perni RB; Wentland MP; Huang JI; Powles RG; Aldous S; Klingbeil KM; Peverly AD; Robinson RG; Corbett TH; Jones JL; Mattes KC; Rake JB; Coughlin SA
    J Med Chem; 1998 Sep; 41(19):3645-54. PubMed ID: 9733489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pyrrolo[3,2-f]quinolines: synthesis and antiproliferative activity.
    Ferlin MG; Gatto B; Chiarelotto G; Palumbo M
    Bioorg Med Chem; 2001 Jul; 9(7):1843-8. PubMed ID: 11425586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitumor activity of ring A- and F-modified hexacyclic camptothecin analogues.
    Sugimori M; Ejima A; Ohsuki S; Uoto K; Mitsui I; Kawato Y; Hirota Y; Sato K; Terasawa H
    J Med Chem; 1998 Jun; 41(13):2308-18. PubMed ID: 9632364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor polycyclic acridines. 7. Synthesis and biological properties of DNA affinic tetra- and pentacyclic acridines.
    Stanslas J; Hagan DJ; Ellis MJ; Turner C; Carmichael J; Ward W; Hammonds TR; Stevens MF
    J Med Chem; 2000 Apr; 43(8):1563-72. PubMed ID: 10780913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.